Contact Us: Call or click here!

SANFORD: (407) 330-2262
ORANGE CITY: (386) 775-7627

Medical Research Group Blog

Type I Diabetes: Research Efforts For Faster Acting Treatments


Insulin is necessary for the body to be able to use sugar. A diagnosis of type 1 diabetes means that your body is no longer producing insulin. Current treatments require patients to inject insulin at least 30 minutes prior to eating, which means that they must follow a strict and regimented dietary schedule. While we have come a long way in the management of Type 1 diabetes, scientists are working hard to develop even better treatments.


One such potential advancement is faster-acting insulin treatments. Faster-acting, or “meal-time”, insulin treatments would mimic normal pancreatic function, giving patients more flexibility in when they administer insulin and, therefore, when they can eat. Additionally, faster-acting insulin could help reduce hypoglycemic episodes, which can lead to severe complications. Lastly, advances in faster-acting insulin treatments could help accelerate the development of an artificial pancreas, a solution, which could eventually cure diabetes.


Here at Medical Research Group of Central Florida, we are participating in these efforts to develop new, faster-acting insulin treatments, and are looking for research volunteers with Type 1 diabetes. Research volunteers will be compensated for their time and travel. Most importantly, research volunteers will help the advancement of type I diabetes treatment.  


Please contact us if you or your loved one has Type 1 diabetes and might be interested.

Want More Information?

Go Back? Print This Article
Leave A Comment

Reader's Comments

Leave a Comment


(Email is required, but will not be published)


SANFORD: 1403 Medical Plaza Drive, Ste 202, Sanford, Florida 32771 | Phone: (407) 330-2262 | Fax: (407) 321-5464

ORANGE CITY: 2725 Rebecca Lane, Ste 107, Orange City, Florida 32763 | Phone: (386) 775-7627 | Fax: (386) 775-0570

Copyright 2012. All rights reserved. Medical Research Group.